Judge Finds No Direct Infringement In Strattera Suit
A federal judge has ruled that several generic-drug makers do not directly infringe a patent related to Eli Lilly & Co.'s drug Strattera, which is used to treat attention deficit/ hyperactivity...To view the full article, register now.
Already a subscriber? Click here to view full article